Roughly 2% of the total CD45+ cells infiltrating the tumor were GFP+ (Figure 1A) and showed population markers broadly used to identify myeloid cells with the following phenotype CD11blo/int, CD11cint, F4/80lo/int, CD8αint, CD24hi, CD103hi, MHCIIhi (Figure 1B). The gene discussed is PTPRC; the disease is neoplasm.